Ind-Swift Limited has informed the Exchange about hearing of second motion petition and next date of hearing
Awaiting price reaction for this filing.
Ind-Swift Limited has informed the stock exchanges that the second motion petition for the Scheme of Arrangement for Amalgamation of Ind-Swift Limited (Transferor) with Ind-Swift Laboratories Limited (Transferee) was heard at the NCLT Chandigarh Bench-II on May 15, 2025. The hearing involved discussion on reports submitted by statutory authorities and the scheme's approval. The next date of hearing has been fixed for May 29, 2025. The scheme is filed under the relevant SEBI Listing Regulations (Regulation 30) requiring disclosure to exchanges. No swap ratio or detailed scheme terms have been disclosed in this particular filing.
The amalgamation remains in the approval stage, with the next hearing on May 29, 2025 likely to be a key milestone. Until NCLT approval is granted, the merger is not effective, so shareholders should watch for further updates on the outcome. A successful amalgamation could simplify the group structure between Ind-Swift and Ind-Swift Laboratories, but the impact on minority shareholders will depend on the swap ratio and other scheme terms.